Hudock, Inc. Cassava Sciences Inc Transaction History

Hudock, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$17.22 - $38.47 $447 - $1,000	-26 Reduced 74.29%	9 $0
Q1 2022 May 02, 2022	SELL	$32.6 - $53.05 $1,858 - $3,023	-57 Reduced 61.96%	35 $1,000
Q4 2021 Jan 19, 2022	BUY	$36.77 - $90.91 $1,029 - $2,545	28 Added 43.75%	92 $4,000
Q3 2021 Nov 09, 2021	SELL	$41.79 - $135.3 $6,435 - $20,836	-154 Reduced 70.64%	64 $3,000
Q2 2021 Aug 09, 2021	SELL	$32.15 - $89.72 $5,561 - $15,521	-173 Reduced 44.25%	218 $18,000
Q1 2021 Apr 26, 2021	BUY	$7.09 - $87.95 $2,772 - $34,388	391 New	391 $17,000

191

13.7M

2.97M

6.55M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $95.4M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.